Overview of Antibiotic and Antifungal Interventions
Jennifer E. Balkus, PhD, MPH1,2 1University of Washington, USA; 2Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Treatment for vaginal infections, including bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), have remained relatively consistent over the past two decades. While approved treatments successfully cure these infections in most cases, recurrence levels are high for both conditions. New strategies are needed that successfully treat BV and VVC, reduce recurrence, and in the case of BV, eliminate species associated with an increased risk of adverse reproductive health outcomes. This presentation will review current global treatment recommendations for BV and VVC, discuss alternative treatment approaches (such as suppressive therapy) to reduce recurrence, and highlight promising novel treatment regimens that are currently undergoing evaluation in clinical trials.
Credits: None available.
You must be logged in and own this product in order to post comments.